Mark E. Gurney

9k citations
75 papers · 7.5k · 3 hit papers · h-index 41

Impact in

Papers in

Mark E. Gurney

75 papers receiving 7.2k citations

Mark E. Gurney's Hit Papers

Associations of semaglutide with first‐time diagnosis of Alzheimer's disease in patients with type 2 diabetes: Target trial emulation using nationwide real‐world data in the US 2024 · 114 citations
1140+10+20Years since publication250500750

Peers

Mark E. Gurney
Comparison fields: 5 of 132
  • Developmental Biology 518
  • Neurology 1.7k
  • Genetics 1.2k
  • Molecular Biology 2.1k
  • Developmental Neuroscience 86
Replace Paul Gissen with:
Paul Gissen United Kingdom
Nigel G. Laing Australia
Nine V.A.M. Knoers Netherlands
Birgit Rathkolb Germany
Richard I. Kelley United States
Ann B. Moser United States
Rita Horváth United Kingdom
Bwee Tien Poll‐The Netherlands
Àngels García‐Cazorla Spain
Fernando Scaglia United States
Mark E. Gurney relative to Paul Gissen United Kingdom Paul Gissen's profile →
Citations per field
00.5×2×3×3.8×
Paul Gissen · 1×
Citations per year

Countries citing papers authored by Mark E. Gurney

Since Specialization
Citations

This map shows the geographic impact of Mark E. Gurney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Gurney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Gurney more than expected).

Fields of papers citing papers by Mark E. Gurney

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark E. Gurney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Gurney. The network helps show where Mark E. Gurney may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark E. Gurney, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark E. Gurney Line = papers co-authored together Mark E. Gurney links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 75 papers — load more, or switch the sort, to bring in the rest.

#Work
1
A variant in CDKAL1 influences insulin response and risk of type 2 diabetes
Hit paper breakdown →
2007884
2
Benefit of vitamin E, riluzole, and gababapentin in a transgenic model of familial amyotrophic lateral sclerosis
Hit paper breakdown →
1996572
3 2003465
4 1980395
5 2009345
6 2001334
7 2001284
8 1998246
9 1997225
10 2005207
11 1994188
12 2021185
13 1981174
14 1982167
15 1997159
16 1998149
17 2020128
18 1998119
19
Associations of semaglutide with first‐time diagnosis of Alzheimer's disease in patients with type 2 diabetes: Target trial emulation using nationwide real‐world data in the US
Hit paper breakdown →
2024114
20 2009109

About Mark E. Gurney

Mark E. Gurney is a scholar working on Neurology, Molecular Biology, Pharmacology, Developmental Biology and Genetics, having authored 75 papers that have together received 7.5k indexed citations. Recurring topics across this work include Phosphodiesterase function and regulation (16 papers), Amyotrophic Lateral Sclerosis Research (15 papers), Inflammatory mediators and NSAID effects (7 papers), Alzheimer's disease research and treatments (5 papers), Dementia and Cognitive Impairment Research (5 papers), Nerve injury and regeneration (5 papers), Genetics and Neurodevelopmental Disorders (5 papers) and Eicosanoids and Hypertension Pharmacology (4 papers). The work is most often cited by research in Developmental Biology (518 citations), Neurology (1.7k citations), Genetics (1.2k citations), Molecular Biology (2.1k citations) and Developmental Neuroscience (86 citations). Mark E. Gurney has collaborated with scholars based in United States, Iceland and China. Frequent co-authors include Masakazu Konishi, Edward D. Hall, Paula K. Andrus, Alex B. Burgin, Rong Xu, Timothy J. Fleck, Ping Zhai, Lawrence C Katz, Jinhe Li and Adele M. Pauley. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Annals of Neurology, Alzheimer s & Dementia, Journal of Alzheimer s Disease and Journal of Neurochemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact